Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial
Clinical trial NCT00648908 · COMPLETED
Trial details
- NCT number
- NCT00648908
- Sponsor
- Acorda Therapeutics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2011-01-01
- Enrollment
- 269
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.